-
Mashup Score: 0
An abstract is unavailable.
Source: journals.lww.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 3Wolters Kluwer Health - 2 year(s) ago
JavaScript Error JavaScript has been disabled on your browser. You must enable it to continue. Here’s how to enable JavaScript in the following browsers: Internet Explorer From the Tools menu, select Options Click the Content tab Select Enable…
Source: lww.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
New #cancer drugs could be brought to the market quicker—and made available more equitably—through significant improvements in procedure that were evolved during the #COVID-19 #pandemic: https://t.co/Jx9gpDCeDE #oncnews #oncologydrugs https://t.co/h6Ir9RFDZf
-
-
Mashup Score: 1Wolters Kluwer Health - 2 year(s) ago
JavaScript Error JavaScript has been disabled on your browser. You must enable it to continue. Here’s how to enable JavaScript in the following browsers: Internet Explorer From the Tools menu, select Options Click the Content tab Select Enable…
Source: lww.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
New #cancer drugs could be brought to the market quicker—and made available more equitably—through significant improvements in procedure that were evolved during the #COVID-19 #pandemic: https://t.co/Jx9gpDCeDE #oncnews #oncologydrugs https://t.co/J4P0Dq98aV
-
-
Mashup Score: 4Wolters Kluwer Health - 3 year(s) ago
JavaScript Error JavaScript has been disabled on your browser. You must enable it to continue. Here’s how to enable JavaScript in the following browsers: Internet Explorer From the Tools menu, select Options Click the Content tab Select Enable…
Source: lww.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
New Today! #FDA Approves Atezolizumab as Adjuvant Treatment for Non-Small Cell Lung Cancer: https://t.co/RM56srr9GW #FDAapprovals #oncologydrugs #NSCLC https://t.co/NGYirTJa1j
-
-
Mashup Score: 1Wolters Kluwer Health - 3 year(s) ago
JavaScript Error JavaScript has been disabled on your browser. You must enable it to continue. Here’s how to enable JavaScript in the following browsers: Internet Explorer From the Tools menu, select Options Click the Content tab Select Enable…
Source: lww.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
#FDA Approves Pembrolizumab Combination for the First-Line Treatment of #CervicalCancer: https://t.co/uG6gaQ3uIa #FDAApprovals #cxca #oncologydrugs https://t.co/jzEAjOeP2Q
-
-
Mashup Score: 1Wolters Kluwer Health - 3 year(s) ago
JavaScript Error JavaScript has been disabled on your browser. You must enable it to continue. Here’s how to enable JavaScript in the following browsers: Internet Explorer From the Tools menu, select Options Click the Content tab Select Enable…
Source: lww.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
PHARMACY FORUM: Learn prescribing information for Pertuzumab/Trastuzumab/Hyaluronidase-Zzxf: https://t.co/o7P1NpTLH5 #oncologydrugs #medtwitter https://t.co/F15r8A7Ljk
-
-
Mashup Score: 0The response rate of alternative treatments for drugs approved on the basis of response rate - 4 year(s) ago
The approval of about one‐third of oncology drugs by the U.S. Food and Drug Administration (FDA) is based on response rate. In some instances, these approvals stem from data collected in single arm t…
Source: Wiley Online LibraryCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
NOW ONLINE Read the new study by Alyson Haslam, Jennifer Gill & Vinay Prasad @VPrasadMDMPH : ➡️https://t.co/pCSLmOpADd | The response rate of alternative treatments for drugs approved on the basis of response rate | @FDA_Drug_Info @FDAOncology #FDA #OncologyDrugs https://t.co/QPbUIjX8oh
-
The #FDA approved updated labeling for #temozolomide under #ProjectRenewal, an initiative aimed at updating labeling information for older #oncologydrugs to ensure information is clinically meaningful and scientifically up-to-date. https://t.co/gJP7cEfMfb https://t.co/31dBQALTAj